Advances in Pathogenesis in IBD (And Implications for Clinical Practice)

Dermot McGovern

​

IBD: Controlled Clinical Trials

Bruce E. Sands, MD, MS

​

IBD 2022 Post DDW: Lessons From Real World Data

Gary R. Lichtenstein, MD

​

Practical Applications of Combining Therapies

David T. Rubin, MD

​

Advances in Therapeutic Monitoring

Raymond Cross, MD, MS, AGAF, FACG

​

Decision Support Tools for IBD

Parambir S. Dulai, MD

​

Positioning IBD Advanced Therapies: Today & Tomorrow

Miguel Regueiro, MD, FACG, AGAF

​

Evolving Role of Microbial Modifications in C. difficile Infection

Paul Feuerstadt, MD, FACG, AGAF

​

State of the Art Helicobacter pylori Management

Colin W. Howden, MD

​

When the Abdominal Bloating/Pain Is More than IBS: CSID, Porphyria, and Other IBS Imposters

Brooks D. Cash, MD